Chart is shaping for a bullish continuation. Short term target is 36-39c #dyor #biotech
Below 7.8 short otherwise accumulate and go #LONG #Bullish Put a trailing stop and let the Market stop you out.
On watch Ascending triangle base forming Price tracking above 20MA May have big resistance at 5.9c Need more volume to kick on
Massive bullish volume, creating demand. Could gap up on Monday. Really cool trade to take. Probable upside from here.
Incoming news on Clinical Trials in a hot M&A sector. Still Relatively cheap at $15 m MC. Solid Science and management at the wheel.
Popped up on my volume alerts and bought on the pullback. Went as high as 10 cents on some pretty strong news! ANNOUNCEMENT: ================================ Melbourne, Australia (10 December 2018): Clinical-stage oncology company Prescient Therapeutics Limited (ASX: PTX; Prescient) is pleased to announce interim durability data on the PTX-200 study in HER2...
So this is another clinical stager.... Coming along with PTX100 and PTX200 studied for breast cancer and incombination with citarabine for acute myeloid leukemia. Technically all levels above 0,13 are a buy!